R-125224

N/A

Report date: 2023/02/18 22:37:05

Base Information

Drug NameR-125224
Drug Alias NameCS-9507R125224
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionApoptosis stimulants
TargetsNot applicable
Therapy Area/IndicationsAutoimmune DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEuropeJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaiichi Sankyo Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A